Our results regarding the possible downregulation of IP-10 in the endometria of patients with endometriosis are to some extent concordant with the data obtained in endometrial biopsy and peritoneal fluid specimens, although this biomarker was characterized by borderline significance [28,29]. The gene discussed is CXCL10; the disease is endometriosis.